FindTrial
Sign In

Prognostic Utility of Left Ventricular Ejection Fraction in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Prognostic Utility of Left Ventricular Ejection Fraction in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis - Prognostic Role of LVEF in TAVI Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000057959
Enrollment
Unknown
Registered
2025-05-25
Start date
2025-05-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic stenosis

Interventions

None listed

Sponsors

Saga University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Studies were included if they met the following criteria: (1) adult patients with AS undergoing TAVI; (2) baseline LVEF assessed using transthoracic echocardiography; (3) clinical outcomes such as all-cause death (ACD), cardiovascular death (CD), or MACE reported; (4) availability of HRs and 95% CIs from univariable or multivariable Cox regression analysis; and (5) sufficient data to calculate effect sizes. If multiple publications involved overlapping cohorts, we included the study with the most detailed or recent data.

Exclusion criteria

Exclusion criteria: Studies that did not analyze LVEF as a continuous variable were excluded.

Design outcomes

Primary

MeasureTime frame
Pooled hazard ratio of LVEF in TAVI patients—

Countries

Japan

Contacts

Public ContactYosuke Nabeshima

Saga University Department of Cardiovascular Medicine

y.nabeshima1016@gmail.com0952316511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026